Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.
Anciaux M, Demetter P, De Wind R, Gomez Galdon M, Vande Velde S, Lens G, Craciun L, Deleruelle A, Larsimont D, Lenaerts T, Sclafani F, Deleporte A, Donckier V, Hendlisz A, Vandeputte C. Anciaux M, et al. Among authors: vandeputte c. BMJ Open Gastroenterol. 2020 Jul;7(1):e000431. doi: 10.1136/bmjgast-2020-000431. BMJ Open Gastroenterol. 2020. PMID: 32675198 Free PMC article.
Fat density is a novel prognostic marker in patients with esophageal cancer.
Anciaux M, Van Gossum A, Wenglinski C, Ameye L, Guiot T, Flamen P, Demetter P, Deleporte A, Sclafani F, Donckier V, Hendlisz A, Vandeputte C. Anciaux M, et al. Among authors: vandeputte c. Clin Nutr ESPEN. 2020 Oct;39:124-130. doi: 10.1016/j.clnesp.2020.07.007. Epub 2020 Aug 11. Clin Nutr ESPEN. 2020. PMID: 32859305
In times of crisis, go liquid!
Hendlisz A, Deleporte A, Vandeputte C. Hendlisz A, et al. Among authors: vandeputte c. Curr Opin Oncol. 2014 Jul;26(4):440. doi: 10.1097/CCO.0000000000000084. Curr Opin Oncol. 2014. PMID: 24840524 No abstract available.
Tackling immunomonitoring in gastrointestinal cancer.
Anciaux M, Vandeputte C, Hendlisz A. Anciaux M, et al. Among authors: vandeputte c. Curr Opin Oncol. 2017 Jul;29(4):296-305. doi: 10.1097/CCO.0000000000000383. Curr Opin Oncol. 2017. PMID: 28505010 Review.
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.
Bregni G, Sticca T, Camera S, Akin Telli T, Craciun L, Trevisi E, Pretta A, Kehagias P, Leduc S, Senti C, Deleporte A, Vandeputte C, Saad ED, Kerger J, Gil T, Piccart-Gebhart M, Awada A, Demetter P, Larsimont D, Hendlisz A, Aftimos P, Sclafani F. Bregni G, et al. Among authors: vandeputte c. Acta Oncol. 2020 Dec;59(12):1438-1446. doi: 10.1080/0284186X.2020.1809704. Epub 2020 Aug 21. Acta Oncol. 2020. PMID: 32820683
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.
Camera S, Akin Telli T, Woff E, Vandeputte C, Kehagias P, Guiot T, Critchi G, Wissam Y, Bregni G, Trevisi E, Pretta A, Senti C, Leduc S, Gkolfakis P, Hoerner F, Rothé F, Sclafani F, Flamen P, Deleporte A, Hendlisz A. Camera S, et al. Among authors: vandeputte c. Cancers (Basel). 2020 Sep 24;12(10):2752. doi: 10.3390/cancers12102752. Cancers (Basel). 2020. PMID: 32987838 Free PMC article.
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.
Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, D'Hondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F. Bregni G, et al. Among authors: vandeputte c. Acta Oncol. 2021 Apr;60(4):549-553. doi: 10.1080/0284186X.2020.1871067. Epub 2021 Jan 13. Acta Oncol. 2021. PMID: 33435735 Clinical Trial. No abstract available.
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.
Deleporte A, Paesmans M, Garcia C, Vandeputte C, Lemort M, Engelholm JL, Hoerner F, Aftimos P, Awada A, Charette N, Machiels G, Piccart M, Flamen P, Hendlisz A. Deleporte A, et al. Among authors: vandeputte c. BMC Cancer. 2014 May 30;14:385. doi: 10.1186/1471-2407-14-385. BMC Cancer. 2014. PMID: 24885112 Free PMC article. Clinical Trial.
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N, Vandeputte C, Ameye L, Bogaert CV, Krygier J, Guiot T, Deleporte A, Delaunoit T, Geboes K, Van Laethem JL, Peeters M, Demolin G, Holbrechts S, Flamen P, Paesmans M, Hendlisz A. Charette N, et al. Among authors: vandeputte c. BMC Cancer. 2019 Feb 12;19(1):134. doi: 10.1186/s12885-019-5319-8. BMC Cancer. 2019. PMID: 30744591 Free PMC article.
58 results